Assay Report
Methods · Standard Curves · QC · Results
Quantify thyroid-stimulating hormone (TSH), thyroid hormones (Free T3, Free T4), thyroglobulin, and thyroid autoantibodies (anti-TPO, anti-Tg) using electrochemiluminescence (ECL) — custom-configurable U-PLEX panels for hypothyroid, hyperthyroid, and autoimmune thyroid disease research.
TSH is the most sensitive indicator of thyroid status — elevated in hypothyroidism, suppressed in hyperthyroidism. Free T3 and Free T4 are the biologically active thyroid hormones regulating metabolism. Thyroglobulin is a thyroid tissue marker. Anti-TPO and anti-Tg autoantibodies are hallmarks of Hashimoto's thyroiditis and Graves' disease. MSD U-PLEX enables custom configuration of these markers in a single multiplex panel — measuring TSH, free hormones, thyroglobulin, and autoantibodies simultaneously from 25 µL serum, with wide dynamic range capturing TSH from <0.01 to >100 mIU/L without dilution.
| Marker | Category | Biological Role | Key Research Applications |
|---|---|---|---|
| TSH | Pituitary | Thyroid-stimulating hormone — HPT axis regulator | Primary screening; hypothyroidism; hyperthyroidism |
| Free T4 (FT4) | Thyroid Hormone | Primary thyroid product — prohormone | Hypothyroidism confirmation; replacement monitoring |
| Free T3 (FT3) | Thyroid Hormone | Most potent thyroid hormone | Deiodinase activity; T3 toxicosis |
| Thyroglobulin (Tg) | Thyroid Tissue | Thyroid follicular cell protein | Post-thyroidectomy monitoring; thyroiditis |
| Anti-TPO | Autoantibody | Anti-thyroid peroxidase | Hashimoto's (>90%); Graves' (70%) |
| Anti-Tg | Autoantibody | Anti-thyroglobulin | Hashimoto's (60–70%) |
Thyroid markers are available as U-PLEX custom configurations. Free hormone measurements (FT3, FT4) are preferred over total T4/T3. For research use only.
Integrated hypothalamic-pituitary-thyroid assessment
TSH screening + free hormone + autoantibody = complete assessment. For research use only.
| Item | Full Service | Notes |
|---|---|---|
| U-PLEX Configuration | Custom | Select 2–10 markers |
| Sample Processing | Included | Free hormone protocol |
| Standard Curves | Per-marker calibrators | Hormone-specific standards |
| Data Report | With ratios & QC | FT3/FT4 ratio included |
For Research Use Only. Not for diagnostic procedures.
Choose TSH, free hormones, thyroglobulin, and autoantibodies.
Serum (SST). Document medications. Ship on dry ice.
Receive TSH + free hormone + autoantibody data with FT3/FT4 ratio.
| Feature | MSD U-PLEX Multiplex | Individual ELISA/CLIA (×N) | Automated Analyzer |
|---|---|---|---|
| Panel Coverage | TSH + FT4 + FT3 + Tg + auto-Ab — one well | 6 separate assays | TSH, FT4, FT3 — no autoantibody |
| Sample (6 markers) | 25 µL total | 600 µL | ~300 µL |
| TSH Dynamic Range | 4–5 logs, no dilution | 2–3 logs, may need dilution | 3–4 logs |
| Autoantibody Integration | Anti-TPO + Anti-Tg in same panel | Separate platform required | Not available |
| Free vs. Total | Free T3/T4 — TBG-independent | Analyte-dependent | Free T4 standard; FT3 less common |
| Customization | Full — select any 2–10 markers | Fixed single-analyte kits | Fixed menu |
Jonklaas, J. et al. (2014) Thyroid. 24(12):1670-1751. "Guidelines for the Treatment of Hypothyroidism." DOI: 10.1089/thy.2014.0028 · PMID: 25266247
Biondi, B. & Cooper, D.S. (2019) Endocrine. 66(1):18-26. "Thyroid hormone therapy for hypothyroidism." DOI: 10.1007/s12020-019-02023-7 · PMID: 31372822
Baloch, Z. et al. (2003) Thyroid. 13(1):3-126. "Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease." DOI: 10.1089/105072503321086962 · PMID: 12625976
De Leo, S. et al. (2016) The Lancet. 388(10047):906-918. "Hyperthyroidism." DOI: 10.1016/S0140-6736(16)00278-6 · PMID: 27038492
McLeod, D.S.A. & Cooper, D.S. (2012) Endocrine. 42(2):252-265. "The incidence and prevalence of thyroid autoimmunity." DOI: 10.1007/s12020-012-9703-2 · PMID: 22644837
Total T4 and Total T3 include protein-bound (>99%) and free (<1%) hormone. TBG levels change in pregnancy, estrogen therapy, and liver disease — altering total hormone levels independently of thyroid status. Free T4 and Free T3 measure only the biologically active unbound fraction and are independent of TBG variations. For research use only.
Autoimmune thyroid disease is the most common cause of thyroid dysfunction. Anti-TPO is present in >90% of Hashimoto's and 70% of Graves'. Including both autoantibodies alongside TSH and free hormones provides confirmation of autoimmune etiology and identification of subclinical autoimmune thyroiditis. For research use only.
Levothyroxine directly elevates Free T4. Liothyronine elevates Free T3 and may suppress TSH. Anti-thyroid drugs reduce Free T4 and Free T3 with compensatory TSH elevation. Document all medications — drug, dose, timing relative to blood draw. For research use only.
MSD U-PLEX supports up to 10 analytes per well. Thyroid and reproductive hormones can be combined within the limit. Check linker compatibility for both small-molecule and protein analytes. An alternative approach: separate thyroid and reproductive panels from the same sample — 25 µL each, 50 µL total. For research use only.
TSH follows a diurnal rhythm — standardize collection timing. For levothyroxine patients, draw blood before the morning dose. Document pregnancy status — hCG stimulates the TSH receptor. SST or EDTA plasma is suitable. For research use only.
Demo Assay Report
Request a representative report to review how assay methods, standard curves, quality-control metrics, and quantitative results are presented.
Online Inquiry
×